UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035909
Receipt number R000040764
Scientific Title Analysis of vonoprazan efficacy against chronic cough in patients with gastroesophageal reflux disease
Date of disclosure of the study information 2019/04/01
Last modified on 2021/08/21 13:13:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of vonoprazan efficacy against chronic cough in patients with gastroesophageal reflux disease

Acronym

Analysis of vonoprazan efficacy against chronic cough

Scientific Title

Analysis of vonoprazan efficacy against chronic cough in patients with gastroesophageal reflux disease

Scientific Title:Acronym

Analysis of vonoprazan efficacy against chronic cough

Region

Japan


Condition

Condition

Gastroesophageal reflux disease

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to evaluate the efficacy of vonoprazan against chronic cough in patients with gastroesophageal reflux disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Japan-Leicester Cough Questionnaire at day 28

Key secondary outcomes

Cough severity visual analogue scale, FSSG questionnaire and adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

proton pump inhibitor: vonoprazan

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)chronic non-productive cough
1)presence of heartburn and acid esophagus
2)presence of throat head symptoms such as thrombosis and hoarseness
3)cough worsens with conversation, meal, get up, upper body flexion and weight gain
4)no medications (such as ACE inhibitors) that cause coughing and bronchodilators, inhaled corticosteroids and antiallergic drugs are ineffective
(2)over 20 years old
(3)written consent form

Key exclusion criteria

(1)abnormal findings of chest X-ray
(2)history of antacid including proton pump inhibitor
(3)allergy to vonoprazan
(4)anti-Human Immunodeficiency Virus drugs
(5)patients judged inappropriate by physician

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Nagano

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine

Zip code

6500017

Address

7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan

TEL

0783825660

Email

tnagano@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Tatsunori
Middle name
Last name Kiriu

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine

Zip code

6500017

Address

7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan

TEL

0783825660

Homepage URL


Email

tkiriu@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital Clinical Translational Research Center

Address

7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan

Tel

0783826669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB

2019 Year 04 Month 01 Day

Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date

2020 Year 08 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 18 Day

Last modified on

2021 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040764


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name